DE69404460T2 - Zell-test für alzheimersche krankheit - Google Patents
Zell-test für alzheimersche krankheitInfo
- Publication number
- DE69404460T2 DE69404460T2 DE69404460T DE69404460T DE69404460T2 DE 69404460 T2 DE69404460 T2 DE 69404460T2 DE 69404460 T DE69404460 T DE 69404460T DE 69404460 T DE69404460 T DE 69404460T DE 69404460 T2 DE69404460 T2 DE 69404460T2
- Authority
- DE
- Germany
- Prior art keywords
- alzheimer
- disease
- cell test
- cells
- intracellular calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/056,456 US5580748A (en) | 1993-05-03 | 1993-05-03 | Diagnostic tests for alzheimers disease |
PCT/US1994/004754 WO1994025872A1 (en) | 1993-05-03 | 1994-05-02 | Cell test for alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69404460D1 DE69404460D1 (de) | 1997-09-04 |
DE69404460T2 true DE69404460T2 (de) | 1998-02-26 |
Family
ID=22004526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69404460T Expired - Fee Related DE69404460T2 (de) | 1993-05-03 | 1994-05-02 | Zell-test für alzheimersche krankheit |
Country Status (12)
Country | Link |
---|---|
US (1) | US5580748A (de) |
EP (1) | EP0697111B1 (de) |
JP (1) | JPH09500202A (de) |
AT (1) | ATE155888T1 (de) |
AU (1) | AU689776B2 (de) |
CA (1) | CA2162048A1 (de) |
DE (1) | DE69404460T2 (de) |
DK (1) | DK0697111T3 (de) |
ES (1) | ES2108455T3 (de) |
GR (1) | GR3025126T3 (de) |
HK (1) | HK1001500A1 (de) |
WO (1) | WO1994025872A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6300085B1 (en) | 1993-05-03 | 2001-10-09 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic method for Alzheimer's disease |
US5976816A (en) * | 1993-05-03 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Cell tests for alzheimer's disease |
US6107050A (en) * | 1993-05-03 | 2000-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic test for alzheimers disease |
US5902732A (en) * | 1995-10-04 | 1999-05-11 | Cytoscan Sciences Llc | Drug screening process measuring changes in cell volume |
US6573063B2 (en) * | 1995-10-04 | 2003-06-03 | Cytoscan Sciences, Llc | Methods and systems for assessing biological materials using optical and spectroscopic detection techniques |
US6183975B1 (en) * | 1997-02-24 | 2001-02-06 | J. Jay Gargus | Method of detection of congenital disease |
AU750582B2 (en) * | 1997-11-10 | 2002-07-25 | Bristol-Myers Squibb Company | Method for diagnosing Alzheimer's disease |
US6087118A (en) * | 1999-03-04 | 2000-07-11 | Bristol-Myers Squibb Company | Method for diagnosing alzheimer's disease |
EP1192462A1 (de) * | 1999-07-01 | 2002-04-03 | Scios Inc. | Verhinderung und behandlung von mit amyloid assoziierten krankheiten |
WO2001077686A2 (en) * | 2000-04-05 | 2001-10-18 | Neurologic, Inc. | Cellular calcium responce for diagnosis of alzheimer's disease |
US6495335B2 (en) * | 2000-12-07 | 2002-12-17 | Mario Chojkier | Compositions and methods for diagnosing alzheimer's disease |
GB0107231D0 (en) | 2001-03-22 | 2001-05-16 | Imp College Innovations Ltd | Patch clamp |
US6825229B2 (en) | 2002-03-07 | 2004-11-30 | Blanchette Rockefeller Neurosciences Institute | Methods for Alzheimer's Disease treatment and cognitive enhancement |
US20050065205A1 (en) * | 2002-03-07 | 2005-03-24 | Daniel Alkon | Methods for Alzheimer's disease treatment and cognitive enhance |
US20080004332A1 (en) * | 2002-03-07 | 2008-01-03 | Alkon Daniel L | Methods for alzheimer's disease treatment and cognitive enhancement |
TW200538181A (en) | 2004-05-18 | 2005-12-01 | Brni Neurosciences Inst | Treatment of depressive disorders |
CA2617003A1 (en) * | 2005-07-29 | 2007-02-08 | Blanchette Rockefeller Neurosciences Institute | Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory |
WO2007056160A2 (en) * | 2005-11-03 | 2007-05-18 | Redpoint Bio Corporation | High throughput screening assay for the trpm5 ion channel |
KR20090038478A (ko) | 2006-07-28 | 2009-04-20 | 블랜체트 록펠러 뉴로사이언시즈 인스티튜트 | 세포 성장 자극, 시냅스 리모델링 및 장기간 기억 강화 방법 |
CN101848726A (zh) * | 2007-02-09 | 2010-09-29 | 布朗歇特洛克菲勒神经科学研究所 | 苔藓抑素、苔藓抑素类似物和其它相关物质对头部创伤引起的记忆缺陷和脑损伤的疗效 |
CL2007002908A1 (es) * | 2007-10-09 | 2008-05-30 | Univ Concepcion | Procedimiento electroquimico in vitro para evaluar capacidad neurotoxica de estructuras, principios activos y/o compuestos de interes en celulas vivas y que comprende medir y cuantificar los parametros electricos en membranas expuestas a dichos agreg |
WO2011041761A1 (en) * | 2009-10-02 | 2011-04-07 | Blanchette Rockefeller Neurosciences Institute | Fibroblast growth patterns for diagnosis of alzheimer's disease |
US20160186263A1 (en) | 2013-05-09 | 2016-06-30 | Trustees Of Boston University | Using plexin-a4 as a biomarker and therapeutic target for alzheimer's disease |
JP2017505756A (ja) | 2013-12-13 | 2017-02-23 | ザ ジェネラル ホスピタル コーポレイション | 可溶性高分子量(hmw)タウ種およびその用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925664A (en) * | 1986-10-20 | 1990-05-15 | University Of Utah | Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function |
JPH03505868A (ja) * | 1988-04-08 | 1991-12-19 | マサチユセツツ・インスチチユート・オブ・テクノロジー | 神経性疾患を治療するための方法及び組成物 |
-
1993
- 1993-05-03 US US08/056,456 patent/US5580748A/en not_active Expired - Fee Related
-
1994
- 1994-05-02 WO PCT/US1994/004754 patent/WO1994025872A1/en active IP Right Grant
- 1994-05-02 AU AU67784/94A patent/AU689776B2/en not_active Ceased
- 1994-05-02 DE DE69404460T patent/DE69404460T2/de not_active Expired - Fee Related
- 1994-05-02 EP EP94915953A patent/EP0697111B1/de not_active Expired - Lifetime
- 1994-05-02 CA CA002162048A patent/CA2162048A1/en not_active Abandoned
- 1994-05-02 AT AT94915953T patent/ATE155888T1/de not_active IP Right Cessation
- 1994-05-02 DK DK94915953.7T patent/DK0697111T3/da active
- 1994-05-02 ES ES94915953T patent/ES2108455T3/es not_active Expired - Lifetime
- 1994-05-02 JP JP6524573A patent/JPH09500202A/ja active Pending
-
1997
- 1997-10-22 GR GR970402758T patent/GR3025126T3/el unknown
-
1998
- 1998-01-15 HK HK98100311A patent/HK1001500A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2108455T3 (es) | 1997-12-16 |
GR3025126T3 (en) | 1998-02-27 |
US5580748A (en) | 1996-12-03 |
DK0697111T3 (da) | 1998-03-02 |
HK1001500A1 (en) | 1998-06-19 |
WO1994025872A1 (en) | 1994-11-10 |
DE69404460D1 (de) | 1997-09-04 |
AU6778494A (en) | 1994-11-21 |
JPH09500202A (ja) | 1997-01-07 |
EP0697111A1 (de) | 1996-02-21 |
ATE155888T1 (de) | 1997-08-15 |
CA2162048A1 (en) | 1994-11-10 |
AU689776B2 (en) | 1998-04-09 |
EP0697111B1 (de) | 1997-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69404460D1 (de) | Zell-test für alzheimersche krankheit | |
ATE235057T1 (de) | Cell test und diagnostischer kit für alzheimer- erkrankung | |
WO1999058981A3 (en) | Diagnostic tests for alzheimer's disease | |
ATE155811T1 (de) | Menschliche cyclooxygenase-2cdna und bestimmung von menschliche cyclooxygenase-2-inhibierung | |
WO2000066762A3 (en) | Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus | |
EP0671920A4 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten. | |
ES2151880T3 (es) | Antagonistas de proteina de coagulacion de la sangre y sus utilizaciones. | |
AR038428A2 (es) | Compuestos fluorados de marcfortina | |
ES2115679T3 (es) | Preparacion de reactivos de tiempo de protrombina a partir de factor de tejido humano recombinante y de fosfolipidos sinteticos y naturales purificados. | |
ATE226247T1 (de) | Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes | |
ATE250625T1 (de) | IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN | |
DE69333076D1 (de) | Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis | |
DE69616340D1 (de) | Fungizide mischungen | |
Seller et al. | Magnesium metabolism in hypertension | |
ATE178074T1 (de) | Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes | |
DK0821593T3 (da) | Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein | |
ATE412435T1 (de) | Verwendung eines färbemittels zur anfärbung von der augenlinsenkapsel oder von an der netzhaut des auges entstandenen membranen | |
Petitti et al. | Physiologic measures in men with and without vasectomies | |
JPS57179109A (en) | Hair treating agent | |
DE69623325D1 (de) | 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus | |
FI951778A0 (fi) | Menetelmä allergian toteamiseksi | |
増山元三郎 et al. | Quasi-constancy of human biochemical individual variability | |
Harrison et al. | Dansyl chloride: relative effect of patch testing time | |
ITMI951409A1 (it) | Uso di l-aspartato di potassio e di magnesio per aumentare la concentrazione ematica di glutammina | |
WO1996024345A3 (de) | Verwendung eines vitamins der k-gruppe gegen einen verlust kognitiver fähigkeiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: CORNELL RESEARCH FOUNDATION, INC., ITHACA, N.Y., U |
|
8339 | Ceased/non-payment of the annual fee |